Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne
Abroad (travel likely)RecruitingPHASE1
Conditions
Acne
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Celerion, Inc., Tempe, Arizona, United States
Nucleus Network, Melbourne, Victoria, Australia